Class 2 Medicines Recall: Advanz Pharma Limited, Mynzepli 40 mg/mL solution for injection in pre-filled syringe, EL(26)A/44

Imported from official source

Alert

Safety Classified by Officially

Mynzepli 40 mg/mL solution for injection in pre-filled syringe

Advanz Pharma Limited are recalling the specified batches of Mynzepli 40 mg/mL solution for injection in pre-filled syringe as a precautionary measure because a small variation in the size of the finger grip could affect how the medicine is administered and potentially pose a risk to patient safety. The finger grip/flange provides a platform/surface for better grip of the syringe. It allows the user to securely hold the pre-filled syringe while applying pressure to the plunger rod during product administration.

Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Advanz Pharma have confirmed that other unaffected batches of Mynzepli 40 mg/mL solution for injection in pre-filled syringe are currently available for distribution.

This is a Pharmacy and Wholesaler level recall, therefore no further action is required by patients.

This product is only administered by a qualified healthcare professional experienced in administering intravitreal injections.

Patients who experience adverse reactions or have any questions about the medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.

For all enquiries and information on this product, please email [email protected], or telephone +44 (0) 208 588 9131.

Recipients of this Medicines Recall should bring it to the attention of relevant contacts by copy of this notice.

NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

This is an extract. The publication continues at the source.

Contains public sector information licensed under the Open Government Licence v3.0. Licence

Read the original at the source: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-advanz-pharma-limited-mynzepli-40-mg-slash-ml-solution-for-injection-in-pre-filled-syringe-el-26-a-slash-44

Officially imported this from Medicines and Healthcare products Regulatory Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
Medicines and Healthcare products Regulatory Agency — imported from official source
Official source
https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency.atom ATOM
Imported
October 29, 2026 11:00
Versions
1 recorded
Identity
https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-advanz-pharma-limited-my...

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.